apricus wealth LLC Sells 194 Shares of Merit Medical Systems, Inc. $MMSI

apricus wealth LLC lessened its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 7.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,310 shares of the medical instruments supplier’s stock after selling 194 shares during the quarter. apricus wealth LLC’s holdings in Merit Medical Systems were worth $216,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Maverick Capital Ltd. bought a new stake in Merit Medical Systems during the first quarter worth $134,517,000. Nuveen LLC bought a new stake in Merit Medical Systems during the first quarter worth $80,679,000. Ameriprise Financial Inc. raised its position in Merit Medical Systems by 109.4% during the first quarter. Ameriprise Financial Inc. now owns 660,394 shares of the medical instruments supplier’s stock worth $69,810,000 after acquiring an additional 345,070 shares in the last quarter. Invesco Ltd. raised its position in Merit Medical Systems by 16.4% during the first quarter. Invesco Ltd. now owns 1,787,289 shares of the medical instruments supplier’s stock worth $188,934,000 after acquiring an additional 251,821 shares in the last quarter. Finally, Driehaus Capital Management LLC raised its position in Merit Medical Systems by 172.9% during the first quarter. Driehaus Capital Management LLC now owns 227,814 shares of the medical instruments supplier’s stock worth $24,082,000 after acquiring an additional 144,350 shares in the last quarter. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Trading Up 1.6%

MMSI stock opened at $83.21 on Tuesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.66 and a current ratio of 4.09. The company’s 50-day simple moving average is $85.38 and its 200 day simple moving average is $89.74. Merit Medical Systems, Inc. has a 52 week low of $78.12 and a 52 week high of $111.45. The company has a market capitalization of $4.93 billion, a PE ratio of 42.24, a price-to-earnings-growth ratio of 2.63 and a beta of 0.58.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Wednesday, July 30th. The medical instruments supplier reported $1.01 EPS for the quarter, beating the consensus estimate of $0.85 by $0.16. Merit Medical Systems had a net margin of 8.31% and a return on equity of 15.07%. The business had revenue of $382.46 million for the quarter, compared to the consensus estimate of $372.47 million. During the same period in the prior year, the company posted $0.92 earnings per share. Merit Medical Systems’s revenue was up 13.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current year.

Insider Activity at Merit Medical Systems

In related news, Director Lynne N. Ward sold 3,000 shares of the company’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $88.56, for a total value of $265,680.00. Following the transaction, the director directly owned 12,809 shares in the company, valued at approximately $1,134,365.04. This represents a 18.98% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 3.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on MMSI. Needham & Company LLC reaffirmed a “buy” rating and set a $108.00 price target on shares of Merit Medical Systems in a research report on Friday, July 18th. Barrington Research reissued an “outperform” rating and issued a $103.00 price objective on shares of Merit Medical Systems in a research report on Tuesday, October 7th. Canaccord Genuity Group increased their price objective on shares of Merit Medical Systems from $103.00 to $104.00 and gave the company a “buy” rating in a research report on Thursday. Wells Fargo & Company dropped their price objective on shares of Merit Medical Systems from $108.00 to $100.00 and set an “overweight” rating on the stock in a research report on Thursday, July 31st. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Merit Medical Systems in a research report on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Merit Medical Systems has an average rating of “Moderate Buy” and an average target price of $106.50.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.